These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 8580033)

  • 1. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
    Cameron JS
    Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Davies SJ; Yewdall VM; Ogg CS; Cameron JS
    Perit Dial Int; 1990; 10(2):135-40. PubMed ID: 2085598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of peritoneal defence mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD).
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Perit Dial Int; 1989; 9(2):115-9. PubMed ID: 2488196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.
    Afthentopoulos IE; Passadakis P; Oreopoulos DG; Bargman J
    Adv Ren Replace Ther; 1998 Jul; 5(3):157-67. PubMed ID: 9686626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
    Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.
    Keane WF; Comty CM; Verbrugh HA; Peterson PK
    Kidney Int; 1984 Mar; 25(3):539-43. PubMed ID: 6376908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Staphylococcus nasal colonization and HIV in end-stage renal failure patients undergoing peritoneal dialysis.
    Ndlovu KCZ; Swe Swe-Han K; Assounga A
    Ren Fail; 2019 Nov; 41(1):303-313. PubMed ID: 30991864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous ambulatory peritoneal dialysis peritonitis: Microbiology and outcomes.
    Pindi G; Kawle V; Sunkara RR; Darbha MS; Garikaparthi S
    Indian J Med Microbiol; 2020; 38(1):72-77. PubMed ID: 32719212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strain differences in the opsonisation of Staphylococcus epidermidis.
    Bennett-Jones DN; Yewdall VM; Gillespie CM; Ogg CS; Cameron JS
    Perit Dial Int; 1989; 9(4):333-9. PubMed ID: 2488390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal host defense mechanisms in peritoneal dialysis.
    Holmes CJ
    Kidney Int Suppl; 1994 Dec; 48():S58-70. PubMed ID: 7700043
    [No Abstract]   [Full Text] [Related]  

  • 14. Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Warady BA; Campoy SF; Gross SP; Sedman AB; Lum GM
    J Pediatr; 1984 Nov; 105(5):726-30. PubMed ID: 6502302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection in continuous ambulatory peritoneal dialysis (CAPD): aetiology, complications and risk factors.
    Lee GS; Woo KT
    Ann Acad Med Singap; 1992 May; 21(3):354-60. PubMed ID: 1416784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal immunoglobulin (IG) treatment in prophylaxis of bacterial peritonitis in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Biomater Artif Cells Artif Organs; 1987; 15(1):151-9. PubMed ID: 3329538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-centre experience: peritoneal dialysis-related infections in patients on long-term dialysis.
    Luvira V; Satirapoj B; Supasyndh O; Chaiprasert A; Ruangkanchanasetr P; Nata N; Kanjanakul I; Supaporn T; Choovichian P; Bijaphala S; Luvira U; Phiboonbanakit D
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S30-6. PubMed ID: 22043564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of continuous ambulatory peritoneal dialysis (CAPD) peritonitis: surgery can be avoided.
    Al-Allak A; Jones R; Stiff R; Dharmasena D; Morris-Stiff G
    Ann R Coll Surg Engl; 2009 Mar; 91(2):118-22. PubMed ID: 19102818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis.
    Gordon DL; Rice JL; Avery VM
    Eur J Clin Microbiol Infect Dis; 1990 Mar; 9(3):191-7. PubMed ID: 2338088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: the effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation.
    Bastani B; Chu N
    Am J Nephrol; 1995; 15(6):468-72. PubMed ID: 8546167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.